ShareholdersThe week in GRC: Shopify seeks approval to protect CEO voting power and M&A insurance market cools Apr 14, 2022Ben Maiden– The Wall Street Journal (paywall) reported that Twitter CEO Parag Agrawal said Elon Musk decided not to join the company’s board of...Read more
BoardroomGovernance Matters podcast: Taking a successful approach to executive pay in M&A Mar 16, 2022Ben MaidenBoards of directors play a key role when it comes to M&A transactions. At the bottom line, they have to determine whether the deal...Read more
ComplianceThe week in GRC: Companies eye vaccine booster mandates and more buybacks expected in 2022 amid regulatory scrutiny Dec 23, 2021Ben MaidenThe Week in GRC will not publish next week due to the holidays and will return in the New Year. In the meantime, Happy Holidays to all...Read more
EnforcementIssuers see drop in volume of securities class action lawsuits, study finds Aug 02, 2021Maria Ward-BrennanAt the mid-year point, the number of securities class action lawsuits filed in federal and state courts is at its lowest level since...Read more
ShareholdersShareholder activism down at half year mark Jul 29, 2021Ben AshwellThe number of companies targeted by an activist during the first half of the year was at its lowest level in more than six years,...Read more
ComplianceTackling compliance risks in cross-border M&A Feb 04, 2021Andrew Bulovsky and Mark Goldberg Olivia RadinThe second half of 2020 saw a 79 percent increase in cross-border M&A compared with the first half of the year – the biggest half-...Read more
ESGThe week in GRC: LGIM to press for ethnic diversity on boards, and companies facing new compliance risks amid pandemic Oct 09, 2020Ben Maiden– According to Reuters , a victory for Joe Biden in the US presidential election would signal the end of a period during which the...Read more
ShareholdersThe outlook for M&A Sep 30, 2020Tim HumanAs the global extent of the Covid-19 outbreak became apparent, M&A deals began to hit the buffers. Xerox pulled its $35 billion...Read more
ShareholdersConsidering poison pills as corporate vaccines amid Covid-19 May 14, 2020Vilena NicoletThe US economy is not immune to the Covid-19 pandemic. Increased market volatility, lower stock prices, the reluctance of shareholders...Read more
BoardroomDealing with activist directors with an M&A agenda Feb 12, 2020Melissa Sawyer and Marc Treviño, Sullivan & CromwellThis past year, more than ever, activist investors called for the companies they targeted to put themselves up for sale or divest...Read more